Semin Respir Crit Care Med 2019; 40(04): 498-507
DOI: 10.1055/s-0039-1696961
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Bacterial Pneumonias in Immunocompromised Patients

Andry Van de Louw*
1   Division of Pulmonary and Critical Care Medicine, Penn State University College of Medicine, Hershey, Pennsylvania
,
Adrien Mirouse*
2   Medical ICU, Hôpital Saint Louis APHP, Paris, France
,
Olivier Peyrony
2   Medical ICU, Hôpital Saint Louis APHP, Paris, France
,
Virginie Lemiale
2   Medical ICU, Hôpital Saint Louis APHP, Paris, France
,
Elie Azoulay
2   Medical ICU, Hôpital Saint Louis APHP, Paris, France
› Author Affiliations
Further Information

Publication History

Publication Date:
04 October 2019 (online)

Abstract

With the overall improvement in survival of cancer patients and the widespread use of novel immunotherapy drugs for malignant as well as nonmalignant diseases, the prevalence of immunosuppression is rising in the population. Immunocompromised patients are particularly exposed to pulmonary infections which remain a leading cause for acute hypoxic respiratory failure and intensive care unit admission. Although fungal or opportunistic infections are always a concern, bacterial pneumonia remains the most common cause of pulmonary infection, is associated with a significant mortality, and has some specificity in this population. Adequate and timely prevention, diagnosis, and management of bacterial pneumonias require knowledge about the complex interplay between host factors (type and severity of immunosuppression) and bacterial pathogenesis, to improve the outcome. We provide an overview of bacterial pneumonias in immunocompromised patients including their epidemiology, risk factors with respect to the pattern of immunosuppression, microbiological characteristics, diagnostic approach, management, and prevention.

* Both authors contributed equally to this work.


 
  • References

  • 1 Miller KD, Siegel RL, Lin CC. , et al. Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 2016; 66 (04) 271-289
  • 2 Azoulay E, Mokart D, Pène F. , et al. Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol 2013; 31 (22) 2810-2818
  • 3 Azoulay E, Pickkers P, Soares M. , et al; Efraim investigators and the Nine-I study group. Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study. Intensive Care Med 2017; 43 (12) 1808-1819
  • 4 Azoulay E, Thiéry G, Chevret S. , et al. The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 2004; 83 (06) 360-370
  • 5 Ruiz M, Ewig S, Marcos MA. , et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999; 160 (02) 397-405
  • 6 Garcia JB, Lei X, Wierda W. , et al. Pneumonia during remission induction chemotherapy in patients with acute leukemia. Ann Am Thorac Soc 2013; 10 (05) 432-440
  • 7 Lossos IS, Breuer R, Or R. , et al. Bacterial pneumonia in recipients of bone marrow transplantation. A five-year prospective study. Transplantation 1995; 60 (07) 672-678
  • 8 Keefer K, Bender R, Liao J, Sivik J, Van de Louw A. Characteristics of pulmonary complications in non-Hodgkin's lymphoma patients treated with rituximab-containing chemotherapy and impact on survival. Ann Hematol 2018; 97 (12) 2373-2380
  • 9 Lee J-O, Kim D-Y, Lim JH. , et al. Risk factors for bacterial pneumonia after cytotoxic chemotherapy in advanced lung cancer patients. Lung Cancer 2008; 62 (03) 381-384
  • 10 Afessa B, Green B. Bacterial pneumonia in hospitalized patients with HIV infection: the pulmonary complications, ICU support, and prognostic factors of hospitalized patients with HIV (PIP) study. Chest 2000; 117 (04) 1017-1022
  • 11 Aguilar-Guisado M, Givaldá J, Ussetti P. , et al; RESITRA cohort. Pneumonia after lung transplantation in the RESITRA cohort: a multicenter prospective study. Am J Transplant 2007; 7 (08) 1989-1996
  • 12 Cisneros JM, Muñoz P, Torre-Cisneros J. , et al; Spanish Transplantation Infection Study Group. Pneumonia after heart transplantation: a multi-institutional study. Clin Infect Dis 1998; 27 (02) 324-331
  • 13 Chang G-C, Wu C-L, Pan S-H. , et al. The diagnosis of pneumonia in renal transplant recipients using invasive and noninvasive procedures. Chest 2004; 125 (02) 541-547
  • 14 Fujita K, Kim YH, Kanai O, Yoshida H, Mio T, Hirai T. Emerging concerns of infectious diseases in lung cancer patients receiving immune checkpoint inhibitor therapy. Respir Med 2019; 146: 66-70
  • 15 Rolston KVI, Nesher L. Post-obstructive pneumonia in patients with cancer: a review. Infect Dis Ther 2018; 7 (01) 29-38
  • 16 De Neve NY, Benoit DD, Depuydt PO. , et al. Aspiration pneumonia: an underestimated cause of severe respiratory failure in patients with haematological malignancies and severe oral mucositis?. Acta Clin Belg 2010; 65 (06) 416-419
  • 17 Bouza E, Burillo A, Muñoz P. Catheter-related infections: diagnosis and intravascular treatment. Clin Microbiol Infect 2002; 8 (05) 265-274
  • 18 Crawford J, Dale DC, Kuderer NM. , et al. Risk and timing of neutropenic events in adult cancer patients receiving chemotherapy: the results of a prospective nationwide study of oncology practice. J Natl Compr Canc Netw 2008; 6 (02) 109-118
  • 19 Pettengell R, Schwenkglenks M, Leonard R. , et al; Impact of Neutropenia in Chemotherapy-European Study Group (INC-EU). Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia study. Support Care Cancer 2008; 16 (11) 1299-1309
  • 20 Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64 (02) 328-340
  • 21 Hübel K, Hegener K, Schnell R. , et al. Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia. Ann Hematol 1999; 78 (02) 73-77
  • 22 Rabello LSCF, Silva JRL, Azevedo LCP. , et al. Clinical outcomes and microbiological characteristics of severe pneumonia in cancer patients: a prospective cohort study. PLoS One 2015; 10 (03) e0120544
  • 23 Meyer E, Beyersmann J, Bertz H. , et al; ONKO-KISS Study Group. Risk factor analysis of blood stream infection and pneumonia in neutropenic patients after peripheral blood stem-cell transplantation. Bone Marrow Transplant 2007; 39 (03) 173-178
  • 24 Gudiol C, Royo-Cebrecos C, Laporte J. , et al. Clinical features, aetiology and outcome of bacteraemic pneumonia in neutropenic cancer patients. Respirology 2016; 21 (08) 1411-1418
  • 25 Gathmann B, Mahlaoui N, Gérard L. , et al; CEREDIH; Dutch WID; European Society for Immunodeficiencies Registry Working Party. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 2014; 134 (01) 116-126
  • 26 Miller DG, Karnofsky DA. Immunologic factors and resistance to infection in chronic lymphatic leukemia. Am J Med 1961; 31: 748-757
  • 27 Friedman H, Yamamoto Y, Klein TW. Legionella pneumophila pathogenesis and immunity. Semin Pediatr Infect Dis 2002; 13 (04) 273-279
  • 28 van der Poll T, Opal SM. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 2009; 374 (9700): 1543-1556
  • 29 Cillóniz C, García-Vidal C, Moreno A, Miro JM, Torres A. Community-acquired bacterial pneumonia in adult HIV-infected patients. Expert Rev Anti Infect Ther 2018; 16 (07) 579-588
  • 30 Duncan MD, Wilkes DS. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections. Proc Am Thorac Soc 2005; 2 (05) 449-455
  • 31 Ahn BK, Lee Y-S, Kim Y-J. , et al. Prediction model for mortality in cancer patients with pneumonia: comparison with CURB-65 and PSI. Clin Respir J 2018; 12 (02) 538-546
  • 32 Schwegler I, von Holzen A, Gutzwiller J-P, Schlumpf R, Mühlebach S, Stanga Z. Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer. Br J Surg 2010; 97 (01) 92-97
  • 33 El-Ghammaz AMS, Ben Matoug R, Elzimaity M, Mostafa N. Nutritional status of allogeneic hematopoietic stem cell transplantation recipients: influencing risk factors and impact on survival. Support Care Cancer 2017; 25 (10) 3085-3093
  • 34 Legoff J, Zucman N, Lemiale V. , et al. Clinical significance of upper airway virus detection in critically ill hematology patients. Am J Respir Crit Care Med 2019; 199 (04) 518-528
  • 35 Rimland D, Navin TR, Lennox JL. , et al; Pulmonary Opportunistic Infection Study Group. Prospective study of etiologic agents of community-acquired pneumonia in patients with HIV infection. AIDS 2002; 16 (01) 85-95
  • 36 Kumar D, Humar A, Plevneshi A. , et al; Toronto Invasive Bacterial Diseases Network. Invasive pneumococcal disease in solid organ transplant recipients--10-year prospective population surveillance. Am J Transplant 2007; 7 (05) 1209-1214
  • 37 Diep BA, Chambers HF, Graber CJ. , et al. Emergence of multidrug-resistant, community-associated, methicillin-resistant Staphylococcus aureus clone USA300 in men who have sex with men. Ann Intern Med 2008; 148 (04) 249-257
  • 38 Bonatti H, Pruett TL, Brandacher G. , et al. Pneumonia in solid organ recipients: spectrum of pathogens in 217 episodes. Transplant Proc 2009; 41 (01) 371-374
  • 39 Nseir S, Di Pompeo C, Diarra M. , et al. Relationship between immunosuppression and intensive care unit-acquired multidrug-resistant bacteria: a case-control study. Crit Care Med 2007; 35 (05) 1318-1323
  • 40 Moreau A-S, Martin-Loeches I, Povoa P. , et al; TAVeM Study Group. Impact of immunosuppression on incidence, aetiology and outcome of ventilator-associated lower respiratory tract infections. Eur Respir J 2018; 51 (03) 1701656
  • 41 Patriarca F, Cigana C, Massimo D. , et al. Risk factors and outcomes of infections by multidrug-resistant gram-negative bacteria in patients undergoing hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2017; 23 (02) 333-339
  • 42 Satlin MJ, Walsh TJ. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: three major threats to hematopoietic stem cell transplant recipients. Transpl Infect Dis 2017 19. (06):. doi: 10.1111/tid.12762
  • 43 Gras J, De Castro N, Montlahuc C. , et al. Clinical characteristics, risk factors, and outcome of tuberculosis in kidney transplant recipients: a multicentric case-control study in a low-endemic area. Transpl Infect Dis 2018; 20 (05) e12943
  • 44 Ombelet S, Van Wijngaerden E, Lagrou K. , et al. Mycobacterium genavense infection in a solid organ recipient: a diagnostic and therapeutic challenge. Transpl Infect Dis 2016; 18 (01) 125-131
  • 45 Wang H-L, Seo Y-H, LaSala PR, Tarrand JJ, Han XY. Nocardiosis in 132 patients with cancer: microbiological and clinical analyses. Am J Clin Pathol 2014; 142 (04) 513-523
  • 46 Abreu C, Rocha-Pereira N, Sarmento A, Magro F. Nocardia infections among immunomodulated inflammatory bowel disease patients: a review. World J Gastroenterol 2015; 21 (21) 6491-6498
  • 47 Sickles EA, Greene WH, Wiernik PH. Clinical presentation of infection in granulocytopenic patients. Arch Intern Med 1975; 135 (05) 715-719
  • 48 Logan PM, Primack SL, Staples C, Miller RR, Müller NL. Acute lung disease in the immunocompromised host. Diagnostic accuracy of the chest radiograph. Chest 1995; 108 (05) 1283-1287
  • 49 Heussel CP, Kauczor HU, Heussel G, Fischer B, Mildenberger P, Thelen M. Early detection of pneumonia in febrile neutropenic patients: use of thin-section CT. AJR Am J Roentgenol 1997; 169 (05) 1347-1353
  • 50 Chavez MA, Shams N, Ellington LE. , et al. Lung ultrasound for the diagnosis of pneumonia in adults: a systematic review and meta-analysis. Respir Res 2014; 15: 50
  • 51 Azoulay E, Mokart D, Rabbat A. , et al. Diagnostic bronchoscopy in hematology and oncology patients with acute respiratory failure: prospective multicenter data. Crit Care Med 2008; 36 (01) 100-107
  • 52 Azoulay E, Mokart D, Lambert J. , et al. Diagnostic strategy for hematology and oncology patients with acute respiratory failure: randomized controlled trial. Am J Respir Crit Care Med 2010; 182 (08) 1038-1046
  • 53 Gadsby NJ, Russell CD, McHugh MP. , et al. Comprehensive molecular testing for respiratory pathogens in community-acquired pneumonia. Clin Infect Dis 2016; 62 (07) 817-823
  • 54 Baudel J-L, Tankovic J, Dahoumane R. , et al. Multiplex PCR performed of bronchoalveolar lavage fluid increases pathogen identification rate in critically ill patients with pneumonia: a pilot study. Ann Intensive Care 2014; 4: 35
  • 55 Rouzaud C, Rodriguez-Nava V, Catherinot E. , et al. Clinical assessment of a nocardia PCR-based assay for diagnosis of nocardiosis. J Clin Microbiol 2018; 56 (06) e00002-18
  • 56 Strålin K, Ehn F, Giske CG. , et al. The IRIDICA PCR/electrospray ionization-mass spectrometry assay on bronchoalveolar lavage for bacterial etiology in mechanically ventilated patients with suspected pneumonia. PLoS One 2016; 11 (07) e0159694
  • 57 Xie Y, Du J, Jin W. , et al. Next generation sequencing for diagnosis of severe pneumonia: China, 2010-2018. J Infect 2019; 78 (02) 158-169
  • 58 Lebeaux D, Morelon E, Suarez F. , et al. Nocardiosis in transplant recipients. Eur J Clin Microbiol Infect Dis 2014; 33 (05) 689-702
  • 59 White DA, Wong PW, Downey R. The utility of open lung biopsy in patients with hematologic malignancies. Am J Respir Crit Care Med 2000; 161 (3, Pt 1): 723-729
  • 60 Mandell LA, Wunderink RG, Anzueto A. , et al; Infectious Diseases Society of America; American Thoracic Society. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis 2007; 44 (Suppl. 02) S27-S72
  • 61 Kalil AC, Metersky ML, Klompas M. , et al. Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis 2016; 63 (05) e61-e111
  • 62 Averbuch D, Orasch C, Cordonnier C, Livermore DM. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica 2013; 98 (12) 1826-1835
  • 63 Mokart D, Slehofer G, Lambert J. , et al. De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study. Intensive Care Med 2014; 40 (01) 41-49
  • 64 Rosa RG, Goldani LZ, dos Santos RP. Association between adherence to an antimicrobial stewardship program and mortality among hospitalised cancer patients with febrile neutropaenia: a prospective cohort study. BMC Infect Dis 2014; 14: 286
  • 65 Smith TJ, Bohlke K, Lyman GH. , et al; American Society of Clinical Oncology. Recommendations for the use of WBC growth factors: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2015; 33 (28) 3199-3212
  • 66 Freifeld AG, Bow EJ, Sepkowitz KA. , et al; Infectious Diseases Society of Americaa. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin Infect Dis 2011; 52 (04) 427-431
  • 67 Delacruz W, Terrazzino S, Osswald M, Payne C, Haney B. Implementing a multidisciplinary approach to enhance compliance with guideline-recommended prechemotherapy pneumococcal vaccination in a military-based medical oncology practice. J Oncol Pract 2017; 13 (11) e966-e971
  • 68 Ishimaru M, Matsui H, Ono S, Hagiwara Y, Morita K, Yasunaga H. Preoperative oral care and effect on postoperative complications after major cancer surgery. Br J Surg 2018; 105 (12) 1688-1696
  • 69 Møller T, Moser C, Adamsen L. , et al. Early warning and prevention of pneumonia in acute leukemia by patient education, spirometry, and positive expiratory pressure: A randomized controlled trial. Am J Hematol 2016; 91 (03) 271-276
  • 70 Perez EE, Orange JS, Bonilla F. , et al. Update on the use of immunoglobulin in human disease: a review of evidence. J Allergy Clin Immunol 2017; 139 (3S): S1-S46
  • 71 Sousa D, Justo I, Domínguez A. , et al. Community-acquired pneumonia in immunocompromised older patients: incidence, causative organisms and outcome. Clin Microbiol Infect 2013; 19 (02) 187-192
  • 72 Sanders KM, Marras TK, Chan CKN. Pneumonia severity index in the immunocompromised. Can Respir J 2006; 13 (02) 89-93
  • 73 Gruson D, Vargas F, Hilbert G. , et al. Predictive factors of intensive care unit admission in patients with haematological malignancies and pneumonia. Intensive Care Med 2004; 30 (05) 965-971
  • 74 Darmon M, Thiery G, Ciroldi M. , et al. Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy. Crit Care Med 2005; 33 (11) 2488-2493
  • 75 Auclin E, Charles-Nelson A, Abbar B. , et al. Outcomes in elderly patients admitted to the intensive care unit with solid tumors. Ann Intensive Care 2017; 7 (01) 26
  • 76 Lemiale V, Mokart D, Resche-Rigon M. , et al; Groupe de Recherche en Réanimation Respiratoire du patient d'Onco-Hématologie (GRRR-OH). Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial. JAMA 2015; 314 (16) 1711-1719
  • 77 Fujiwara Y, Yamaguchi H, Kobayashi K. , et al. The therapeutic outcomes of mechanical ventilation in hematological malignancy patients with respiratory failure. Intern Med 2016; 55 (12) 1537-1545
  • 78 Lee HY, Rhee CK, Lee JW. Feasibility of high-flow nasal cannula oxygen therapy for acute respiratory failure in patients with hematologic malignancies: a retrospective single-center study. J Crit Care 2015; 30 (04) 773-777
  • 79 Schnell D, Mayaux J, Lambert J. , et al. Clinical assessment for identifying causes of acute respiratory failure in cancer patients. Eur Respir J 2013; 42 (02) 435-443
  • 80 Yoo H, Suh GY, Jeong B-H. , et al. Etiologies, diagnostic strategies, and outcomes of diffuse pulmonary infiltrates causing acute respiratory failure in cancer patients: a retrospective observational study. Crit Care 2013; 17 (04) R150
  • 81 Azoulay E, Lemiale V, Mokart D. , et al. Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical trial. JAMA 2018; 320 (20) 2099-2107
  • 82 Mokart D, Lambert J, Schnell D. , et al. Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma 2013; 54 (08) 1724-1729
  • 83 Rabe C, Mey U, Paashaus M. , et al. Outcome of patients with acute myeloid leukemia and pulmonary infiltrates requiring invasive mechanical ventilation-a retrospective analysis. J Crit Care 2004; 19 (01) 29-35
  • 84 Depuydt PO, Benoit DD, Roosens CD, Offner FC, Noens LA, Decruyenaere JM. The impact of the initial ventilatory strategy on survival in hematological patients with acute hypoxemic respiratory failure. J Crit Care 2010; 25 (01) 30-36
  • 85 Rabbat A, Chaoui D, Lefebvre A. , et al. Is BAL useful in patients with acute myeloid leukemia admitted in ICU for severe respiratory complications?. Leukemia 2008; 22 (07) 1361-1367
  • 86 Lemiale V, Resche-Rigon M, Mokart D. , et al. High-flow nasal cannula oxygenation in immunocompromised patients with acute hypoxemic respiratory failure: a Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique study. Crit Care Med 2017; 45 (03) e274-e280
  • 87 Neuschwander A, Lemiale V, Darmon M. , et al; A Groupe de Recherche en Réanimation Respiratoire en Onco-Hématologie (GRRR-OH) study. Noninvasive ventilation during acute respiratory distress syndrome in patients with cancer: Trends in use and outcome. J Crit Care 2017; 38: 295-299
  • 88 Decavèle M, Rivals I, Marois C. , et al. Etiology and prognosis of acute respiratory failure in patients with primary malignant brain tumors admitted to the intensive care unit. J Neurooncol 2019; 142 (01) 139-148